Sponsor Pipeline

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06649708 HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies Advanced Solid Tumor Malignancies Recruiting
NCT07333469 A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma Solid Tumor and Lymphoma Not Yet Recruiting
Get alerts when Hanx Biopharmaceuticals (Wuhan) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free